Global Acute Sinusitis Market 2023-2029

Global Acute Sinusitis Market 2023-2029

Acute sinusitis is a condition characterized by inflammation and swelling of the mucous membranes that line the sinuses. It often occurs as a result of a viral or bacterial infection, causing the sinus cavities to become blocked, filled with secretions, and unable to properly drain. In cases of severe or recurring sinusitis, further treatment such as allergy testing, immunotherapy, or surgery may be necessary. It is important to manage acute sinusitis to avoid more serious complications such as the spread of infection or the formation of chronic sinusitis. According to the latest estimates, the global acute sinusitis market is set to achieve an incremental growth of USD 1.4 billion, accelerating at a CAGR of almost 7.52% during the forecast period 2023-2029.

The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global acute sinusitis market. It presents a quantitative analysis of the market to enable stakeholders to capitalize on the prevailing market opportunities. The report also identifies top segments for opportunities and strategies based on market trends and leading competitors’ approaches.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the diagnosis & treatment, end user, and region. The global market for acute sinusitis can be segmented by diagnosis & treatment: treatment, diagnosis. The treatment segment held the largest share of the global acute sinusitis market in 2022 and is anticipated to hold its share during the forecast period. Acute sinusitis market is further segmented by end user: hospitals & clinics, research centers, others. Globally, the hospitals & clinics segment made up the largest share of the acute sinusitis market. Based on region, the acute sinusitis market is segmented into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America. Europe was the largest contributor to the global acute sinusitis market in 2022.

The treatment market is further segmented into saline nasal spray, nasal corticosteroids, decongestants, OTC pain relievers, antibiotics, allergy shots. In 2022, the saline nasal spray segment made up the largest share of revenue generated by the acute sinusitis market. Furthermore, the diagnosis market has been categorized into nasal endoscopy, imaging test, allergy testing, laboratory test. Among these, the nasal endoscopy segment was accounted for the highest revenue generator in 2022.

Market Segmentation

By diagnosis & treatment: treatment, diagnosis

By end user: hospitals & clinics, research centers, others

By region: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America

The report also provides a detailed analysis of several leading acute sinusitis market vendors that include Bayer AG, Novartis AG, Sanofi SA, GlaxoSmithKline plc, Abbott Laboratories, Bristol Myers Squibb plc, AstraZeneca plc, Dr. Reddy’s Laboratories, Ltd., among others. In this report, key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.



Scope of the Report

• To analyze and forecast the market size of the global acute sinusitis market.
• To classify and forecast the global acute sinusitis market based on diagnosis & treatment, end user, region.
• To identify drivers and challenges for the global acute sinusitis market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global acute sinusitis market.
• To identify and analyze the profile of leading players operating in the global acute sinusitis market.

• Gain a reliable outlook of the global acute sinusitis market forecasts from 2023 to 2029 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.